AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+4.88%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$3.82B
(+0.03%)
Cap. Flow
-$255M
Cap. Flow
% of AUM
-6.66%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
328
New
76
Increased
85
Reduced
65
Closed
72
Top Buys
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$33.5M |
| 2 |
FIVE9
FIVN
|
$33.1M |
| 3 |
Domino's
DPZ
|
$32.9M |
| 4 |
Incyte
INCY
|
$28.6M |
| 5 |
Humana
HUM
|
$23.6M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$91.8M |
| 2 |
Aligos Therapeutics
ALGS
|
$60.1M |
| 3 |
Exact Sciences
EXAS
|
$59.2M |
| 4 |
Sanofi
SNY
|
$53M |
| 5 |
Keurig Dr Pepper
KDP
|
$49.6M |
Sector Composition
| 1 | Healthcare | 68.01% |
| 2 | Consumer Discretionary | 11.66% |
| 3 | Consumer Staples | 8.76% |
| 4 | Technology | 8.5% |
| 5 | Communication Services | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Domino's
DPZ
$15.6B
| $43.5M | 0.7% |
101,176
+76,415
| +309% | +$32.9M |
|
27
Dyne Therapeutics
DYN
$1.92B
| $41.5M | 0.66% |
1,155,204
+184,313
| +19% | +$6.62M |
|
28
Alkermes
ALKS
$4.85B
| $40.5M | 0.65% |
1,448,654
-1,250,525
| -46% | -$35M |
|
29
Immunocore
IMCR
$1.63B
| $39.3M | 0.63% |
1,264,000
+288,000
| +30% | +$8.97M |
|
30
Treace Medical Concepts
TMCI
$453M
| $35.9M | 0.57% |
6,196,000
+836,000
| +16% | +$4.85M |
|
31
Ironwood Pharmaceuticals
IRWD
$213M
| $33.8M | 0.54% |
8,200,000
+400,000
| +5% | +$1.65M |
|
|
32
Sanofi
SNY
$121B
| $33.4M | 0.53% |
580,000
-920,000
| -61% | -$53M |
|
33
SentinelOne
S
$5.9B
| $33.3M | 0.53% |
1,393,196
+898,561
| +182% | +$21.5M |
|
34
Voyager Therapeutics
VYGR
$186M
| $30.4M | 0.49% |
5,200,000
| – | – |
|
35
Datadog
DDOG
$47B
| $29.9M | 0.48% |
260,000
+60,817
| +31% | +$7M |
|
36
Toast
TOST
$25.5B
| $28.9M | 0.46% |
1,020,235
-342,334
| -25% | -$9.69M |
|
37
Intuitive Surgical
ISRG
$170B
| $28.2M | 0.45% |
57,326
-13,901
| -20% | -$6.83M |
|
38
Boston Beer
SAM
$2.41B
| $27.7M | 0.44% |
95,807
-1,485
| -2% | -$429K |
|
39
Prothena Corp
PRTA
$441M
| $27.6M | 0.44% |
1,650,000
+90,000
| +6% | +$1.51M |
|
40
Treehouse Foods
THS
$926M
| $26.1M | 0.42% |
622,000
-161,000
| -21% | -$6.76M |
|
41
DocuSign
DOCU
$15B
| $25M | 0.4% |
402,894
-195,027
| -33% | -$12.1M |
|
|
AUTL
42
Autolus Therapeutics
AUTL
$375M
| $24.9M | 0.4% |
6,872,000
+622,000
| +10% | +$2.26M |
|
43
Rigel Pharmaceuticals
RIGL
$697M
| $24.9M | 0.4% |
1,536,000
-88,000
| -5% | -$1.42M |
|
44
Sensient Technologies
SXT
$4.82B
| $23.4M | 0.37% |
291,814
+25,009
| +9% | +$2.01M |
|
45
Levi Strauss
LEVI
$8.95B
| $23.3M | 0.37% |
1,070,000
+723,000
| +208% | +$15.8M |
|
46
Planet Fitness
PLNT
$8.79B
| $22.3M | 0.36% |
274,369
-39,845
| -13% | -$3.24M |
|
47
Texas Roadhouse
TXRH
$11.5B
| $22.1M | 0.35% |
125,076
-4,817
| -4% | -$851K |
|
48
Vertex Pharmaceuticals
VRTX
$100B
| $21.5M | 0.34% |
46,129
+10,070
| +28% | +$4.68M |
|
49
GSK
GSK
$78.5B
| $21.4M | 0.34% |
524,000
-976,000
| -65% | -$39.9M |
|
|
PARA
50
DELISTED
Paramount Global Class B
PARA
| $21.2M | 0.34% |
+2,000,000
| New | +$21.2M |
|